Chemours Net Invested Capital from 2010 to 2024

CC Stock  USD 26.48  0.11  0.42%   
Chemours' Net Invested Capital is decreasing over the years with slightly volatile fluctuation. Net Invested Capital is expected to dwindle to about 3.9 B. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
4.8 B
Current Value
3.9 B
Quarterly Volatility
279.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours main balance sheet or income statement drivers, such as Depreciation And Amortization of 313.9 M, Interest Expense of 146.3 M or Selling General Administrative of 797.3 M, as well as many exotic indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0409 or PTB Ratio of 8.43. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
  
This module can also supplement Chemours' financial leverage analysis and stock options assessment as well as various Chemours Technical models . Check out the analysis of Chemours Correlation against competitors.

Latest Chemours' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Chemours Co over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Chemours' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

Chemours Net Invested Capital Regression Statistics

Arithmetic Mean4,843,975,238
Geometric Mean4,835,470,726
Coefficient Of Variation5.77
Mean Deviation156,166,349
Median4,972,000,000
Standard Deviation279,714,397
Sample Variance78240.1T
Range1.1B
R-Value(0.64)
Mean Square Error49447.9T
R-Squared0.41
Significance0.01
Slope(40,202,143)
Total Sum of Squares1095362T

Chemours Net Invested Capital History

20243.9 B
20234.8 B
20224.7 B
20214.8 B
20204.8 B
20194.8 B
2018B

About Chemours Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chemours income statement, its balance sheet, and the statement of cash flows. Chemours investors use historical funamental indicators, such as Chemours's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Chemours investors may use each financial statement separately, they are all related. The changes in Chemours's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemours's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemours Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemours. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital4.8 B3.9 B

Pair Trading with Chemours

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Moving against Chemours Stock

  0.63DNMR Danimer Scientific Financial Report 8th of May 2024 PairCorr
  0.58ECL Ecolab Inc Financial Report 7th of May 2024 PairCorr
  0.55CMT Core Molding Technologies Financial Report 14th of May 2024 PairCorr
  0.51ASH Ashland Global Holdings Financial Report 7th of May 2024 PairCorr
  0.49CBT Cabot Financial Report 13th of May 2024 PairCorr
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:
Check out the analysis of Chemours Correlation against competitors.
Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.91)
Dividend Share
1
Earnings Share
(1.60)
Revenue Per Share
40.473
Quarterly Revenue Growth
0.017
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.